04/22/2026
Why Submit Your Research to MSToronto2026?
Presenting at the 10th Joint ACTRIMS-ECTRIMS Meeting places your work on a global stage alongside leaders in multiple sclerosis research, clinical care, and therapeutic innovation.
Submitting an abstract allows you to:
β
Share discoveries in Clinical Aspects of MS
β
Advance understanding of Pathology & Pathogenesis
β
Highlight progress in Imaging & Non-Imaging Biomarkers
β
Contribute to innovation in Therapy
Accepted abstracts will be presented as oral or poster presentations, and published in the Multiple Sclerosis Journal online supplement, giving your research international visibility and lasting impact.
π
Abstract deadline: May 7, 2026
π Submit your abstract: https://mstoronto2026.org/call-for-abstracts/